New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Ocular Therapeutix, Inc.
OCUL
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2B

Biotechnology

Next Earning date - 05 Nov 2024

2B

Biotechnology

Next Earning date - 05 Nov 2024

11.14USD
Shape0.25 ( 2.30%)
favorite-chart

Relative Strenght

17
favorite-chart

Volume Buzz

-39%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

4%

Quote Panel

Shape
Updated October 26, 2024
1W -2.02 % 1M 28.34 % 3M 36.35 % 1Y 360.33 %

Key Metrics

Shape
  • Market Cap

    1.74B


  • Shares Outstanding

    155.92M


  • Share in Float

    134.99M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    11.14


  • Average Volume

    1.16M


  • Beta

    1.282


  • Range

    1.995-11.6


  • Industry

    Biotechnology


  • Website

    https://www.ocutx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

27.88x

P/S Ratio

4.78x

P/B Ratio

0.2

Debt/Equity

-227.2%

Net Margin

$-1.1

EPS

How OCUL compares to sector?

P/E Ratio

Relative Strength

Shape

OCUL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$75M

Shape356%

2025-Revenue

$1.00

Shape-286%

2025-EPS

$75M

Shape-76%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

upgrade

Previous: Hold

2024-06-20

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.30
vs -0.23

Q4.22

arrow
arrow

N/A

-0.24
vs -0.23

Q1.23

arrow
arrow

N/A

-0.31
vs -0.22

Q2.23

arrow
arrow

N/A

-0.27
vs -0.28

Q3.23

arrow
arrow

N/A

-0.51
vs -0.30

Q4.23

arrow
arrow

N/A

-0.28
vs -0.24

Q1.24

arrow
arrow

N/A

-0.24
vs -0.31

Q2.24

arrow
arrow

N/A

-0.24
vs -0.27

Q3.24

arrow
arrow

N/A

-0.24
vs -0.51

Q4.24

arrow
arrow

N/A

-0.22
vs -0.28

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-2%

12M  vs 12.2M

Q4.22

arrow
arrow

+14%

14.1M  vs 12.3M

Q1.23

arrow
arrow

+1%

13.4M  vs 13.2M

Q2.23

arrow
arrow

+24%

15.2M  vs 12.3M

Q3.23

arrow
arrow

+25%

14.9M  vs 12M

Q4.23

arrow
arrow

+5%

14.8M  vs 14.1M

Q1.24

arrow
arrow

+10%

14.7M  vs 13.4M

Q2.24

arrow
arrow

+8%

16.4M  vs 15.2M

Q3.24

arrow
arrow

+15%

17.1M  vs 14.9M

Q4.24

arrow
arrow

+20%

17.8M  vs 14.8M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-58%

-0.58
vs -0.27

Q4.22

arrow
arrow

-33%

-0.33
vs -0.58

Q1.23

arrow
arrow

-375%

-3.75
vs -0.33

Q2.23

arrow
arrow

-670%

-6.70
vs -3.75

Q3.23

arrow
arrow

-7%

-0.07
vs -6.70

Q4.23

arrow
arrow

-32%

-0.32
vs -0.07

Q1.24

arrow
arrow

-16%

-0.16
vs -0.32

Q2.24

arrow
arrow

-12%

-0.12
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

135

135
vs 125

8%

Q4.22

arrow
arrow

121

121
vs 135

-10%

Q1.23

arrow
arrow

132

132
vs 121

9%

Q2.23

arrow
arrow

142

142
vs 132

8%

Q3.23

arrow
arrow

118

118
vs 142

-17%

Q4.23

arrow
arrow

122

122
vs 118

3%

Q1.24

arrow
arrow

152

152
vs 122

25%

Q2.24

arrow
arrow

151

151
vs 152

-1%

Earnings Growth

Latest News